Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/8/2025

Mechanism of Action of Vyvanse

Primary Mechanisms of Action

  • The American Academy of Child and Adolescent Psychiatry emphasizes that amphetamines increase the release of dopamine and norepinephrine into the extraneuronal space, providing an additional mechanism beyond reuptake blockade alone 1

Clinical Significance of the Dual Mechanism

  • The combination of reuptake inhibition and enhanced release results in a substantial increase in synaptic dopamine and norepinephrine concentrations, which improves executive function, impulse control, and working memory deficits characteristic of ADHD 1
  • This dual action distinguishes amphetamines from medications like methylphenidate, which primarily work through reuptake inhibition with less direct effect on neurotransmitter release 2
  • Enhanced monoamine signaling in the prefrontal cortex and striatum is associated with improved ADHD symptoms 1
  • The dual mechanism (both blocking reuptake AND increasing release) is what makes amphetamines particularly effective for ADHD, with 70-80% response rates when properly titrated 2, 3

REFERENCES

1

Mechanism of Action and Clinical Implications of Vyvanse [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

3

Medication Options for Managing Both Mood Symptoms and ADHD [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026